Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for postoperative symptoms after rhinoplasty-related surgery
IRCT20240208060937N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexamethasone in postoperative pain, postoperative nausea and vomiting (PONV) and postoperative delirium (POD) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Postoperative pain, Postoperative nausea and 2 more. Started Feb 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)postoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20240208060937N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240208060937N1.